Related Experiment Video
Updated: Feb 2, 2026
In vivo Imaging of Optic Nerve Fiber Integrity by Contrast-Enhanced MRI in Mice
Published on: July 22, 2014
Intratumoral Spatial Heterogeneity at Dynamic Contrast-Enhanced MRI for Assessing Tertiary Lymphoid Structures in
Mengshi Dong1, Xin Jin1, Lina Zhang1
1Department of Radiology, The Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, Guangdong, China.
Background:
Tertiary lymphoid structures (TLS) are associated with enhanced antitumor immune activity in hepatocellular carcinoma (HCC). Dynamic contrast-enhanced (DCE)-MRI-based habitat imaging may enable noninvasive TLS identification.
Purpose:
To develop and validate a DCE-MRI-based habitat model to noninvasively identify TLS status in HCC.
Study Type:
Retrospective.
Subjects:
Three hundred and thirty-four patients (mean age, 53.59 years ±11.38; male = 296; training set:test set = 200:134) with pathologically confirmed HCC.
Field Strength/Sequence:
1.5-T/3.0-T, contrast-enhanced three-dimensional gradient-recalled-echo T1-weighted sequence.
Assessment:
Tumor habitats were identified from DCE-MRI via k-means clustering of voxel-wise enhancement patterns. Habitat-derived features and radiomics features were extracted. Five identification models were developed: clinical model, radiomics model, habitat model, clinical-radiomics model, and clinical-radiomics-habitat (hybrid) model. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC).
Statistical Tests:
Receiver operating characteristic (ROC) curve analysis, area under the precision-recall curve (AUPRC), DeLong test, decision curve analysis, Spiegelhalter's Z test. Significance level: p < 0.05 (two-sided).
Results:
Four habitats with distinct dynamic enhancement patterns were identified. The hybrid model demonstrated the highest discrimination in the training and test sets (AUC = 0.83 [95% CI: 0.78, 0.89] and 0.84 [95% CI: 0.78, 0.91]). It significantly outperformed the clinical-radiomics model (AUC = 0.78 [95% CI: 0.72, 0.84] and 0.77 [95% CI: 0.69, 0.85]), radiomics model (AUC = 0.76 [95% CI: 0.70, 0.83] and 0.75 [95% CI: 0.67, 0.83]), and clinical model (AUC = 0.70 [95% CI: 0.63, 0.78] and 0.68 [95% CI: 0.58, 0.77]) in both sets. Compared to the habitat model (AUC = 0.78 and 0.80), the hybrid model showed significantly better training performance but comparable test performance (p = 0.09).
Conclusion:
A hybrid model combining clinical, radiomics, and habitat-derived features was developed for identifying TLS status.
Technical Efficacy:
Stage 2.
More Related Videos
06:24Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
Published on: April 18, 2015
09:09Laser Capture Microdissection of Glioma Subregions for Spatial and Molecular Characterization of Intratumoral Heterogeneity, Oncostreams, and Invasion
Published on: April 12, 2020
Related Concept Videos
01:21Tertiary Healthcare System
02:15Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme...
01:12Nomenclature of Secondary and Tertiary Amines
01:16Primary Lymphoid Organs
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
02:20Dynamic Equilibrium
01:18Lymphoid Cells and Tissues
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...